SCHEMBL6682328

SCHEMBL6682328

CCC(CC)(CO)C(O)(O[Si](C)(C)C)O[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8651811 0.68 TSHR (0.39)
SCHEMBL4585951 0.67
SCHEMBL3818414 0.67
SCHEMBL7629228 0.66 ALDH1A1 (0.31)
SCHEMBL4586136 0.64
SCHEMBL8596691 0.62
SCHEMBL4585954 0.62
SCHEMBL2168737 0.61 TSHR (0.35)
SCHEMBL20536810 0.61
SCHEMBL6911339 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0927183-B1 SPIROCYCLIC METALLOPROTEASE INHIBITORS PROCTER & GAMBLE (US) 2004-07-28 EP disclosed
US-6015912-A TREATING ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS, SKIN DISORDERS, OCULAR DISORDERS, INFLAMMATION, GUM DISEASE THE PROCTER & GAMBLE COMPANY (US) 2000-01-18 US disclosed
EP-0927183-A1 SPIROCYCLIC METALLOPROTEASE INHIBITORS THE PROCTER &amp; GAMBLE COMPANY (US) 1999-07-07 EP disclosed
WO-1998008850-A1 SPIROCYCLIC METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1998-03-05 WO disclosed